Litcius/Paper detail

On the origins of SARS-CoV-2 main protease inhibitors

Yves L. Janin

2023RSC Medicinal Chemistry44 citationsDOIOpen Access PDF

Abstract

inhibitors owe some of their origins to previous work on other proteases, we first provided a description of various inhibitors of cysteine-bearing human caspase-1 or cathepsin K, as well as inhibitors of serine proteases such as human dipeptidyl peptidase-4 or the hepatitis C protein complex NS3/4A. This is then followed by a description of the results of the approaches adopted (repurposing, structure-based and high throughput screening) to discover coronavirus main protease inhibitors.

Topics & Concepts

ProteasesProteaseRepurposingCysteine proteaseVirologyCathepsinNS3Protease inhibitor (pharmacology)Computational biologyBiologyChemistryEnzymeBiochemistryVirusEcologyViral loadAntiretroviral therapyComputational Drug Discovery MethodsSARS-CoV-2 and COVID-19 ResearchSynthesis and biological activity
On the origins of SARS-CoV-2 main protease inhibitors | Litcius